Sanfe Revolutionizes Feminine Skincare with Glycoclear Technology: A Game-Changer in the Retail Industry

In a market saturated with body care products focused on fragrance and moisturization, Sanfe, an IIT Delhi startup, is revolutionizing the feminine skincare industry with its groundbreaking Glycoclear Technology. Founded by Archit Agarwal and Harry Sehrawat, Sanfe is setting a new standard in skincare by addressing complex body care issues faced by Indian women.

The inspiration behind Glycoclear Technology came from observing the lack of confidence in female colleagues at a farewell party, leading Agarwal and Sehrawat to dedicate months to research and development. The result is a skincare solution that combines alpha-hydroxy acids (AHAs) and beta-hydroxy acids (BHAs) in the Glycoclear Complex, offering immediate exfoliation and nourishment for smoother skin.

With a mission to empower women beyond just products, Sanfe aims to address a broader spectrum of women’s body needs. Co-Founder Archit Agarwal emphasizes the importance of instilling confidence and liberation in every woman through their products. The trademark granted to Glycoclear Technology solidifies Sanfe’s position as a pioneer in skincare innovation, challenging traditional beauty standards.

Sanfe’s financial commitment to innovation is evident in its impressive growth projections, with a turnover of Rs 47.5 crore for FY 2022-23 and a target of achieving Rs 500 crore in the next three years. Through various funding rounds, Sanfe has raised $3.93 million, with distribution channels spanning online platforms, dermatologists, and salons.

As Sanfe propels into a new era of skincare, the Glycoclear Technology range comprises 18 dermatologist-approved products tailored to boost women’s confidence and well-being. With a focus on research, innovation, and challenging beauty standards, Sanfe is not just a skincare solution but a testament to redefining beauty standards in the Indian retail landscape.